PITTSBURGH & SACRAMENTO, Calif.–(BUSINESS WIRE)–Today, Abridge and Sutter Health announced they will make Abridge’s generative AI platform for clinical documentation available to groups of its physicians across California. Sutter Health expects the broad deployment to improve patients’ experiences by helping support more focused face-time with clinicians.
The large not-for-profit, integrated health system sees innovation as a way to transform the entire healthcare landscape and appreciates fellow innovators focused on technology that can benefit physicians and those in their care.
“There is tremendous momentum behind our collective efforts, and it has the ability to change lives for the better,” said Warner Thomas, president and CEO, Sutter Health. “We are highly focused on innovation as a lever to help us achieve our vision and mission of delivering safe, high quality, equitable care to all of our patients. Sutter is equally committed to the thoughtful integration of emerging technologies like AI in healthcare that support our physicians to help deliver on that mission.”
For physicians and advanced practice clinicians, Abridge generates a draft note in real-time based on the clinical conversation that flows directly into the electronic health record. Once clinicians review and verify the note, their paperwork is complete. Abridge is available in more than 14 languages and over 50 specialties, which is a unique advantage as Sutter serves one of the most diverse patient populations in the U.S.
“The technology is designed to fit easily into our teams’ day-to-day workflows inside Epic and will help us better serve our patients by eliminating the burden of clinical documentation that can detract from patient-clinician interactions,” said Laura Wilt, chief digital officer, Sutter Health.
At Sutter Health and all across the country, physicians spend significant time outside of work on administrative tasks like writing clinical notes. Less cognitive load has been shown to directly correlate with reductions in clinician burnout.
“We want to support our clinicians so they can sustainably serve our patients,” said Dr. Albert Chan, chief health information officer, Sutter Health. “Reducing administrative burden by two to three hours a day with Abridge can reduce ‘pajama time’—the time that our clinicians have historically spent away from their families—and help our providers recharge and be the best versions of themselves when caring for patients.”
Sutter also shares Abridge’s passion for rapidly developing and deploying innovative new solutions. For example, Sutter will partner with Abridge to integrate patient-facing summaries into the electronic medical record. Studies have shown that 40-80% of the medical information patients hear during office visits is forgotten immediately, and that clinical documentation does not always cover the details from medical encounters that patients wish to revisit and better understand.
“Clinicians often don’t have time to write detailed patient Instructions and summaries that reflect the details from their conversation that would most benefit the patient,” said Dr. Shiv Rao, CEO and founder, Abridge. “This is a prime use case for generative AI, and it’s a privilege to team up with those from Sutter Health on this new patient-centered initiative.”
This news follows successful deployments of the Abridge technology at Yale New Haven Health System, UCI Health, Emory Healthcare, The University of Kansas Health System, UPMC, and dozens of other health systems. Most recently, Abridge announced a $150M Series C financing, which includes a strategic investment from NVIDIA, that will allow them to accelerate their bold research and development plan. This work will power improvements to Abridge’s existing product lines, and also enable a new wave of possibilities in the future.
Sutter Health recently announced the launch of a new innovation center – a dedicated space to foster creative solutions to some of today’s biggest healthcare challenges. Located in San Francisco, this space will serve as a dynamic hub for creative solutions that will shape the future of healthcare.
About Abridge
Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. The AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients.
Abridge’s enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time with deep EMR integrations. Powered by Linked Evidence and their auditable AI, Abridge is the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems.
About Sutter Health
Sutter Health is a not-for-profit, people-centered healthcare system providing comprehensive care throughout California. Sutter Health is committed to health equity, community partnerships, and innovative, high-quality patient care. Today, Sutter Health is pursuing a bold new plan to reach more people and make excellent health care more connected and accessible. The health system’s 57,000+ staff and clinicians and 12,000+ affiliated physicians currently serve more than 3 million patients with a focus on expanding opportunities to serve patients, people, and communities better. Sutter Health provides exceptional, affordable care through its hospitals, medical groups, ambulatory surgery centers, urgent care clinics, telehealth, home health, and hospice services. Dedicated to transforming health care, at Sutter Health, getting better never stops. Learn more about how Sutter Health is transforming health care at www.sutterhealth.org and www.vitals.sutterhealth.org.
Contacts
Jill O’Brien
press@abridge.com
860-391-5236
Liz Madison
liz.madison@sutterhealth.org
916-396-5156
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…